Oulès, Bénédicte
Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease. [electronic resource]
- The Journal of neuroscience : the official journal of the Society for Neuroscience Aug 2012
- 11820-34 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
ISSN: 1529-2401
Standard No.: 10.1523/JNEUROSCI.0875-12.2012 doi
Subjects--Topical Terms: Alzheimer Disease--complications Aminophenols--therapeutic use Amyloid Precursor Protein Secretases--genetics Amyloid beta-Peptides--metabolism Amyloid beta-Protein Precursor--genetics Analysis of Variance Animals Brain--cytology Caffeine--pharmacology Calcium--metabolism Calcium Channel Blockers--therapeutic use Cells, Cultured Cytosol--drug effects Dantrolene--pharmacology Disease Models, Animal Embryo, Mammalian Endoplasmic Reticulum--drug effects Enzyme Inhibitors--therapeutic use Exploratory Behavior--drug effects Gene Expression Regulation--drug effects Humans Inositol 1,4,5-Trisphosphate Receptors--genetics Maleimides--therapeutic use Maze Learning--drug effects Membrane Potentials--drug effects Membrane Proteins--metabolism Memory Disorders--drug therapy Mice Mice, Transgenic Muscle Relaxants, Central--pharmacology Mutation--genetics Nerve Tissue Proteins--metabolism Neuroblastoma--pathology Neurons--drug effects Patch-Clamp Techniques Peptide Fragments--metabolism Phosphorylation--drug effects Plaque, Amyloid--metabolism Purines--therapeutic use RNA, Messenger--metabolism Reaction Time--drug effects Recognition, Psychology--drug effects Roscovitine Ryanodine Receptor Calcium Release Channel--genetics Transfection